Q2 FY2026 · ended Jun 30, 2026 · Revenue $239,000, -51.6% YoY · Filed Aug 17, 2026
ENvue Medical, Inc. (FEED) files with the SEC under industry code 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $239,000 and a net loss of $4.9 million. Free cash flow was -$2.7 million. As of Jun 30, 2026 it held $1.1 million in cash and investments and $230,000 in total debt.
Company profile
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Listed as
- FEED (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Tyler, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1326706
- Former names
- NanoVibronix, Inc. (until Dec 12, 2025); Nano Vibronix, Inc. (until Mar 25, 2014); Nano Vibronix Inc (until May 5, 2005)
Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical Inc ISRG
- Edwards Lifesciences Corp EW
- STERIS plc STE
- Zimmer Biomet Holdings, Inc. ZBH
- Smith & Nephew PLC SNN
- Align Technology Inc ALGN
- MSA Safety Inc MSA
- Establishment Labs Holdings Inc. ESTA
All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $239,000 | $653,000 | $312,000 | $722,000 | $494,000 |
| Operating income | -$5.5M | -$3.7M | -$14.8M | -$2.2M | -$4.0M |
| Net income | -$4.9M | -$3.8M | -$12.9M | $510,000 | -$4.0M |
| Diluted EPS | -$1.98 | -$6.88 | -$12.45 | -$0.91 | -$1.03 |
| Operating cash flow | -$2.7M | -$4.3M | -$2.7M | -$2.0M | -$3.4M |
| Free cash flow | -$2.7M | -$4.3M | -$2.7M | -$2.0M | -$3.4M |
| Total assets | $38.4M | $39.9M | $41.1M | $54.4M | $51.5M |
| Total liabilities | $7.6M | $7.9M | $7.6M | $11.9M | $11.0M |
| Stockholders' equity | $30.8M | $32.0M | $33.5M | $42.5M | $40.5M |
| Cash and investments | $1.1M | $2.2M | $4.2M | $7.0M | $4.0M |
| Total debt | $230,000 | $130,000 | $117,000 | $127,000 | $150,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, New debt, Bylaw or fiscal year change
|
Oct 14, 2026 | Oct 8, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Aug 31, 2026 | Aug 28, 2026 |
| 10-Q | Quarterly report | Aug 17, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Aug 14, 2026 | Aug 14, 2026 |
| 8-K |
Current report
Material agreement
|
Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 14, 2026 | Jul 14, 2026 |
All 551 ENvue Medical, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.